ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma

SIMPLE SUMMARY: It is known that 9–15% of esophageal adenocarcinoma (EAC) tumors have ARID1A mutations. Studies have shown that ARID1A mutations play a role in the tumor immune phenotype. We aimed to investigate the immunomodulating effects of ARID1A deficiency in EAC. Our study implicates that ARID...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Le, Zheng, Yueyuan, Chien, Wenwen, Ziman, Benjamin, Billet, Sandrine, Koeffler, H. Phillip, Lin, De-Chen, Bhowmick, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670331/
https://www.ncbi.nlm.nih.gov/pubmed/38001638
http://dx.doi.org/10.3390/cancers15225377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670331/
https://www.ncbi.nlm.nih.gov/pubmed/38001638
http://dx.doi.org/10.3390/cancers15225377

Ejemplares similares